About Me
Certified Specialties
Internal Medicine - American Board of Internal Medicine
Neurology - American Board of Psychiatry & Neurology
Faculty Appointments
Professor (Part-Time) - Department of Neurology (SMD)
Credentials
Education
MD | Univ Rochester Sch Med/Dent. Medicine. 1971
BA | Univ of Pennsylvania. Psychology. 1967
Awards
Honorary Member, The Movement Disorder Society. 2009
Member (elected), Institute of Medicine of the National Academies. 2008
Best Doctors in America. 2007 - 2008
Outstanding Leadership, Parkinson Study Group 20 Years of Service. 2006
Stanley Fahn Lecturer, Movement Disorder Society. 2006
H. Houston Merritt Lecturer, American Academy of Neurology. 2005
J.L. Silversides Lecturer, University of Toronto. 2005
Chair, Organizing Committee, Thomas N. Chase Symposium, NINDS. 2004
Co-Chair, Organizing Committee, Inaugural World Parkinson Congress. 2004 - 2006
Louis C. Lasagna Memorial Lecturer, Tufts University. 2004
Stephen J. Fink Memorial Lecturer, Boston University. 2004
Chair, Program Committee, World Congress on Huntington's Disease. 2003
Member, Scientific Advisory Board, Hereditary Disease Foundation. 2003 - 2007
Member, National Institute of Neurological Disorders and Stroke (NINDS) Advisory Council. 2002 - 2005
Principal Investigator, Prospective Huntington At Risk Observational Study, NIH (HG02449). 2002 - 2007
Scientific Advisory Board, Dystonia Medical Research Foundation. 2002 - 2006
Editorial Board, Neurology Today. 2001
Edward Fogan Lecture, University of Buffalo. 2001
Member, Science Committee, American Academy of Neurology. 2001 - 2003
America's Top Doctors (Castle Connoly/Marquis), 1st - 4th editions. 2001 - 2004
First Vice President, American Neurological Association. 2001 - 2002
President, American Society Experimental Neurotherapeutics (ASENT). 2001 - 2003
Nathan L. Cohen Neurology Resident Guest Lectureship, Johns Hopkins University. 2000
American Academy of Neurology Movement Disorder Award. 2000
Rochester Academy of Medicine Award of Merit. 2000
Editorial Committee, Disease Markers. 2000
Chair (Elected), Executive Committee, Parkinson Study Group. 2000 - 2006
University of Rochester Neurology Faculty Award. 1999
Director, Huntington's Disease Society of America/University of Rochester Center of Excellence. 1999
First John B. Penney Jr. Memorial Lecture, Massachusetts General Hospital. 1999
President-Elect, American Society Experimental Neurotherapeutics (ASENT). 1999 - 2001
Member, National Neurofibromatosis Foundation Research Advisory Board. 1998
Editorial Board, Current Treatment Options in Neurology. 1998
Guthrie Family Humanitarian Award, Huntington's Disease Society of America. 1998
First Robert S. Klayman Memorial Lecture in Parkinson's Disease Research, Washington University. 1998
Member, Scientific Advisory Board, Hereditary Disease Foundation. 1998 - 2002
Chair, Program Committee, American Society of Experimental NeuroTherapeutics (ASENT). 1997 - 1999
Secretary, American Neurological Association. 1997 - 2001
Milton Wexler Award for Huntington's Disease Research, Huntington's Disease Society of America. 1997
Representative (ANA), National Committee on Research in Neurological & Communicative Disorders & Stroke. 1997
Representative (ANA), National Foundation for Brain Research. 1997
Treasurer, Movement Disorder Society. 1997 - 1999
The Best Doctors in America: Northeast Region, Woodward/White Inc., 1st edition.. 1996 - 1997
Chair (Elected), Executive Committee, Huntington Study Group. 1996 - 2002
Expert Consultant, FDA, Special Government Employee. 1996
Associate Editor, Archives of Neurology. 1996
Member, Program Review Committee, Dana Foundation. 1995
Representative (University of Rochester), US Pharmacopeia. 1995
Member, Nominating Committee, American Neurological Association. 1994
Member, University of Rochester, Chair of Department of Psychiatry Search Committee. 1994 - 1996
Chair, Public Policy Committee, American Neurological Association. 1994 - 1997
Invited Lecturer, Sigma Tau Foundation, Lectures on Aging. 1994
Member, Research for Rett Syndrome Scientific Review Committee. 1994
Chair, Performance and Safety Monitoring Board, NINDS. 1994
Director, AAN Course. 1994 - 1998
Chair (Elected), Executive Committee, Parkinson Study Group. 1994 - 2000
Treasurer-Elect, Movement Disorder Society. 1994 - 1996
Member, International Editorial Board, CNS Drugs. 1993
Principal Investigator, The Pew-McDonnell. 1993 - 1996
Director, National Parkinson Foundation-University of Rochester Center of Excellence. 1993
Chair, Executive Committee, Huntington Study Group. 1993 - 1996
Member, Scientific Advisory Board, Hereditary Disease Foundation. 1993 - 1997
Member, American Academy of Neurology Decade of the Brain Advisory Committee. 1992 - 1994
Councilor, American Neurological Association. 1992 - 1994
Member, FDA Peripheral and Central Nervous System Advisory Committee. 1992 - 1996
Member, American Academy of Neurology, Legislative Affairs Committee. 1992
The Best Doctors in America, Woodward/White Inc. 1st, 2nd ,3rd, and 4th editions. 1992 - 1999
Co-chair, Subcommittee on Clinical Research, American Academy of Neurology. 1991 - 1992
Chair, American Neurological Association Scientific Program Advisory Committee. 1991 - 1993
Distinguished Achievement in Medicine Award, Modern Medicine. 1991
Member, Professional Advisory Board, Children with Attention Deficit Disorders (ChADD). 1991 - 1995
Robert Graves Professorship, Albany Medical College. 1991
Member, Program Committee, WFN Research Group on Huntington's Disease. 1991 - 1993
Good Housekeeping's list of The 400 Best Doctors in America. 1991
University of Rochester, Louis C. Lasagna Professor of Experimental Therapeutics, Named Chair. 1990
National Science Council, Huntington's Disease Society of America. 1990 - 1994
Scientific Advisory Council, Huntington Society of Canada. 1990
Member, NIA Clinical Trial Oversight Committee. 1990
Editorial Board, Acta Neurologica Scandinavica. 1990 - 1997
Public Policy Fellowship, Joseph P. Kennedy Jr. Foundation. 1990 - 1991
Co-Director, NIH Training Program: Experimental Therapeutics of Neurological Disorders (NS-07338). 1990
Scientific Advisory Board, Dystonia Medical Research Foundation. 1990 - 1995
Member, Phase I Panel, NIH General Clinical Research Centers. 1989
Town and Country's List of Outstanding Medical Specialists in the United States. 1989
Landacre Society Lecturer, Ohio State University. 1988
Editorial Board, Experimental Neurology. 1988
Member, Ad Hoc Review Committee on Alzheimer Centers, NIA. 1988
Faculty Advisory Board, The Journal of the University of Rochester Medical Center. 1988 - 1990
Chair, University of Rochester, Director of Biostatistics Search Committee. 1988 - 1989
Neurologist, NIH-NINCDS Neurologic Disorders Program (HD in Venezuela). 1988 - 1994
Principal Investigator,Deprenyl & Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP), NIH-NINCDS(RO1-NS-24778). 1987 - 1995
Member, Medical Advisory Board, American Parkinson Disease Association. 1987 - 1995
Member, Education Committee, American Academy of Neurology. 1987 - 1993
Member, Program Committee, American Neurological Association. 1987 - 1989
Neurologist, NIH-NINCDS Neurologic Disorders Program (HD in Peru). 1987
Reviewer, Orphan Drug Division, FDA. 1986 - 1987
Honor Award, Huntington's Disease Foundation of America; National Huntington's Disease Association. 1986
Member, University of Rochester Committee on Tenure and Promotions (elected). 1985 - 1988
Chair, University of Rochester Clinical Research Center Advisory Committee. 1985 - 1990
Member, FDA Peripheral and Central Nervous System Drugs Advisory Committee. 1985 - 1988
Consultant, AMA Drug Evaluations. 1985 - 1986
Editorial Board, Movement Disorders. 1985 - 1992
Steering Committee, Movement Disorders. 1985 - 1988
Scientific Advisory Board, Dystonia Medical Research Foundation. 1984 - 1988
Director, Parkinson Disease Program, Watertown, NY. 1983 - 1985
Member, Scientific Program Advisory Committee, NIH, NINCDS. 1983
Member, Huntington's Disease Research Roster Advisory Committee. 1983
Editorial Board, Clinical Neuropharmacology. 1982
Principal Investigator, Baclofen As Protective Therapy in HD, NIH-NINCDS (RO1-NS-17978). 1982 - 1990
Assistant Editor, Archives of Neurology. 1982 - 1996
Member, Scientific Advisory Board, Hereditary Disease Foundation. 1982 - 1990
Consultant, Neurology Division, Bureau of Drugs, FDA. 1981 - 1985
Member, Section on Neuropharmacology, American Academy of Neurology. 1981
Neurologist, NIH-NINCDS Neurologic Disorders Program (HD in Venezuela). 1981 - 1986
National Science Council, Committee to Combat Huntington's Disease, Chairman. 1981 - 1987
Medical Advisory Board, United Parkinson Foundation. 1980 - 1994
National Science Council, Committee to Combat Huntington's Disease. 1980
Member, Huntington's Chorea Research Group, World Congress of Neurology. 1979
Medical Consultant, National Huntington's Disease Association. 1979 - 1986
Medical Consultant, Committee To Combat Huntington's Disease. 1979 - 1986
Teacher-Investigator Development Award (NS00397), NINCDS. 1978 - 1983
Fellow, Fourth Intensive Study Program, Neurosciences Research Program. 1977
Buswell Research Fellow, University of Rochester School of Medicine. 1977 - 1978
Chair, Clinical Care Work Group, U.S. Commission for the Control of Huntington's and Its Consequences. 1976 - 1977
Diploma of Recognition of Merit for Humanitarian Services (conferred by Ambassador of Bolivia to the United States). 1975
Consulting Physician, Rochester Chapter of Committee to Combat Huntington's Disease. 1975
Alpha Omega Alpha, Honor Medical Society. 1971
M.D. with Honors, University of Rochester School of Medicine. 1971
Summer Research Fellowship, University of Rochester, in Cambridge, England. 1970
American Epilepsy Foundation Fellowship. 1968
B.A. Psychology with honors, University of Pennsylvania. 1967
Publications
Books
Experimental Therapeutics of Movement Disorders (1983)
Authors: Fahn, S, Calne DM, Shoulson I (editors)
Publisher: Raven Press, New York City 1983